Long-Acting Injectables Curb Schizophrenia Readmission
Patients with schizophrenia discharged on an LAI antipsychotic had significantly lower 30-day psychiatric readmission rates than those sent home with an oral antipsychotic.
Medscape Medical News
source https://www.medscape.com/viewarticle/long-acting-injectable-antipsychotics-reduce-schizophrenia-2024a10002nf?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/long-acting-injectable-antipsychotics-reduce-schizophrenia-2024a10002nf?src=rss
Comments
Post a Comment